Overview

Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers

Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the systemic exposure of Granexin® gel after topical application to human subjects' diabetic foot ulcers.
Phase:
Phase 1
Details
Lead Sponsor:
FirstString Research, Inc.
Collaborators:
Medical University of South Carolina
Spartanburg Regional Healthcare System